Antibodies News and Research

RSS

Research reports full efficacy of Sotrovimab against BQ.1.1 viral replication in a non-human primate challenge model

Researchers used a non-human primate model to show that Sotrovimab, a commercial mAb also known as Xevudy, was fully effective against SARS-CoV-2 Omicron BA.5 sub-lineage and its derivatives, such as BQ.1.1.

17 Feb 2023

Anti-heparin antibodies develop in patients with spontaneous heparin-induced thrombocytopenia without heparin exposure

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Spontaneous heparin-induced thrombocytopenia is a pro-thrombotic syndrome in which anti-heparin antibodies develop without heparin exposure.

17 Feb 2023

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Researchers determined the prevalence of antibodies against the SARS-CoV-2 spike glycoprotein following three or more doses of COVID-19 vaccines among immunocompromised individuals.

17 Feb 2023

Elevated level of α-synuclein aggregates in stool samples can indicate early form of Parkinson’s

The so-called isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance.

16 Feb 2023

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Researchers evaluated the effectiveness of nirmatrelvir–ritonavir in preventing coronavirus disease 2019 (COVID-19) severity outcomes during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant predominance.

16 Feb 2023

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumour cells must do to survive. Researchers from the Wellcome Sanger Institute found that cancer cells use signals to attract certain types of immune cell and instruct them not to attack.

16 Feb 2023

Study highlights the interconnectedness of autoimmunity and cancer

In a recent study published in the journal Immunity, researchers reviewed the T cell response in cancer and autoimmunity to propose strategies for more effective immunotherapies.

15 Feb 2023

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

A study conducted by US-based scientists claims that bivalent mRNA booster vaccines do not have any added benefits over monovalent booster vaccines in terms of inducing robust and durable neutralizing antibody response against omicron subvariants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Feb 2023

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Scientists at The University of Queensland have developed a novel vaccine for Japanese encephalitis virus (JEV) in pigs, to help stop the spread of the disease in Australia.

15 Feb 2023

Electrochemical method helps to continuously witness and analyze details of protein folding

Scientists are not yet clear on how the tau protein changes from a benign protein essential for normal function in our brains into the toxic neurofibrillary tangles that are a signature of Alzheimer's and other neurodegenerative diseases.

15 Feb 2023

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.

15 Feb 2023

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

In a recent study posted to the bioRxiv* preprint server, researchers identified a novel antiviral pathway different from the interferon (IFN) pathway that inhibited poxvirus(es) replication.

15 Feb 2023

New insights into the role of T-cells during long COVID

Researchers characterize the trajectory of long COVID in patients eight months after recovering from infection.

14 Feb 2023

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Researchers assess longitudinal alterations in SARS-CoV-2 IgG antibody titers after vaccination.

13 Feb 2023

Omicron variant of SARS-CoV-2 is less infectious in dogs and cats

Researchers assess the susceptibility of cats and dogs to the SARS-CoV-2 Omicron variant.

13 Feb 2023

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

A recent study examines the neutralization of SARS-CoV-2 Omicron sub-variants by sera from boosted individuals and those with breakthrough infection.

13 Feb 2023

Similar autoantibody profiles in long COVID and fully recovered individuals

Researchers evaluate autoreactive antibody profiles after SARS-CoV-2 infection.

13 Feb 2023

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the capability of two small molecules of disintegrating alpha-synuclein fibrils.

13 Feb 2023

Researchers uncover the cellular basis for sex-specific differences in COVID-19 patients

COVID-19 has had a huge global impact since the initial outbreak in 2019. Men and women show different responses to this disease, with men having a higher risk from infection.

13 Feb 2023

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Researchers developed spherical hydrogel inhalation for enhanced lung defense to protect against SARS-CoV-2 infections.

13 Feb 2023

Antibodies News and Research

Research reports full efficacy of Sotrovimab against BQ.1.1 viral replication in a non-human primate challenge model

Anti-heparin antibodies develop in patients with spontaneous heparin-induced thrombocytopenia without heparin exposure

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Elevated level of α-synuclein aggregates in stool samples can indicate early form of Parkinson’s

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

Study highlights the interconnectedness of autoimmunity and cancer

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Electrochemical method helps to continuously witness and analyze details of protein folding

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

New insights into the role of T-cells during long COVID

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Omicron variant of SARS-CoV-2 is less infectious in dogs and cats

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

Similar autoantibody profiles in long COVID and fully recovered individuals

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Researchers uncover the cellular basis for sex-specific differences in COVID-19 patients

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Immunology eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest Life Science News